Enfuvirtide (Fuzeon)
Overview
A 36-amino acid synthetic peptide that inhibits HIV-1 entry into CD4+ T-cells by blocking the gp41-mediated membrane fusion step. Enfuvirtide binds to the first heptad repeat (HR1) region of gp41, preventing the conformational change required for viral-cell membrane fusion.
Mechanism of Action
It is the first and only FDA-approved fusion inhibitor and is active against HIV-1 strains resistant to other antiretroviral drug classes.
Research Summary & Key Findings
FDA-approved in 2003 for treatment-experienced HIV-1 patients. TORO trials demonstrated approximately 1 log10 greater viral load reduction when added to optimized background regimen vs. background alone. Limited by twice-daily subcutaneous injections and frequent injection site reactions. Reserved for heavily treatment-experienced patients due to convenience limitations.
Clinical Status
Enfuvirtide (Fuzeon) has received FDA approval and is available for clinical use under appropriate medical supervision. Consult a qualified healthcare provider for prescribing information.
Administration Routes
References
Primary literature
- PubMed — "Enfuvirtide"
Peer-reviewed literature indexed by the National Library of Medicine.
- ClinicalTrials.gov — "Enfuvirtide"
Registered interventional and observational studies, including status and phase.
- PubChem — "Enfuvirtide"
Chemical structure, molecular properties, and bioactivity data.
Study-level citations for this compound are being verified against the primary sources before publication. The database queries above return the current indexed literature in the meantime.
Related Peptides in Antimicrobial
Magainin 2
Research PhaseMagainin 2 is a 23-amino acid antimicrobial peptide originally isolated from the skin of the African clawed frog Xenopus...
View detailsPexiganan (MSI-78)
In Clinical TrialsPexiganan is a 22-amino acid synthetic analog of magainin 2 designed to enhance antimicrobial potency and proteolytic st...
View detailsOmiganan
In Clinical TrialsOmiganan is a synthetic 12-amino acid cationic antimicrobial peptide derived from indolicidin, a naturally occurring pep...
View detailsIseganan (IB-367)
InvestigationalIseganan is a 17-amino acid synthetic analog of protegrin, a naturally occurring antimicrobial peptide found in porcine ...
View detailsStart Your Consultation
Get an AI-proposed Enfuvirtide (Fuzeon) protocol reviewed by a physician in our network.
Start Your ConsultationFind a Pharmacy
Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Enfuvirtide (Fuzeon).
Pharmacy DirectoryJoin the Association
Access exclusive peptide protocols, provider resources, and community support.
List Your PracticeDisclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol. See our editorial policy for how this content is produced and reviewed.